http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010538008-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010538008-A |
| titleOfInvention | Calcium glycerophosphate for treating and preventing respiratory diseases or symptoms |
| abstract | Calcium glycerophosphate has been found to be effective in treating and preventing respiratory diseases, disorders and / or symptoms. The disease, disorder, and / or symptom is associated with symptoms of obstruction or restraint of the respiratory airway. The disease, disorder and / or symptom is respiratory inflammatory disease, respiratory stenosis or nasal inflammatory disease such as asthma, chronic obstructive pulmonary disease (COPD), emphysema, reactive airway dysfunction disease (RADS), Rhinitis, bronchitis, bronchiolitis, nasal congestion, sinusitis, tonsillitis or laryngitis, postnasal drip (PND) and related complications, inflammatory and non-degranulated mast cell activity, goblet Any stimulating dyspnea, restraint or obstruction that causes mucus secretion from the cells; airway narrowing or blockage or mucus interference; sleep apnea, snoring, inflammatory or non-inflammatory responses to allergens or stimulants in the air or non-air May be nasal or non-nasal airway inflammation or irritation causing problems in any area of the body; and physical damage to the respiratory system. Methods, compositions and devices are described for using calcium glycerophosphate to treat and prevent respiratory diseases, disorders and / or symptoms. |
| priorityDate | 2007-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.